Inpharma Weekly

, Volume 1620, Issue 1, pp 4–4 | Cite as

High-dose vs approved-dose fulvestrant for ER+ breast cancer

Clinical study
  • 3 Downloads

Keywords

Breast Cancer Estrogen Postmenopausal Woman Labelling Index Evaluable Patient 

Copyright information

© Adis International Ltd 2008

Personalised recommendations